
EBMT_Cellular_Therapy
@theebmt_ctiwp
EBMT working party on cellular therapy and immunobiology. CTIWP Chair Annalisa Ruggeri, MD, PhD, CIC 813, vicechair Jurgen Kuball, secretary Florent Malard
ID: 3361663613
06-07-2015 01:57:07
5,5K Tweet
2,2K Takipçi
194 Takip Edilen


9000 it was and let’s go for the 10.000: Celebrating the registration of 9.000 patients treated with CAR T cell... sciencedirect.com/science/articl… Christian Chabannon EBMT_Cellular_Therapy Annalisa Ruggeri Anna Sureda The EBMT GoCART_Coalition

Last days of a survey of GoCART_Coalition T2EVOLVE EBMT_Cellular_Therapy on the needs for ATMP development. Which system or sensors we need, viral or non viral? One participant per hospital / company needed. surveymonkey.com/r/ATMPfaciliti…

SBTMO meeting & The EBMT !Thank you for coming & sharing your knowledge with us. Anna Sureda DrDonalMcLornan Carmelo Gurnari Krzysztof Kałwak Annalisa Ruggeri Nico Gagelmann Francesco Onida Nicolaus Kroeger , Per Ljungman, Juliana Silva & the president of SBTMO Fernando Barroso 🔝


🎉Congratulations Thierry Facon for receiving the Myeloma Society award! IACH COMy Mohamad Mohty



Joined meeting in Milano CART in auto immune diseases and finally a joined picture of our amazing team 😀 Annalisa Ruggeri Jurgen Kuball Florent Malard Simona Pagliuca


Great ADWP & CTIWP joint meeting in Milano on innovative cellular therapies and #CARTcells in #autoimmunediseases. Starting a new era together! Thanks to all the speakers, chairs and attendees. The EBMT EBMT_Cellular_Therapy Annalisa Ruggeri Elisa Roldan Jurgen Kuball


The 1st Joint Educational Meeting of the Autoimmune Diseases & EBMT_Cellular_Therapy Working Parties in Milan was a success! 👏 The event brought together top experts and a broad international audience to discuss advances in cellular therapies, particularly CAR-T, in relation to



🔎 Have you seen this publication in Bone Marrow Transplantation? 📰 Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working

Honored and happy to present #ASH2024 on behalf of The EBMT, The EBMT Lymphoma WP, EBMT_Cellular_Therapy and all my co-authors on the European experience with tisacel for patients with r/r #NHL Annalisa Ruggeri Anna Sureda Jurgen Kuball Ibrahim Yakoub-Agha @univamu CRCM - Cancer Research Centre of Marseille




Work supported by EBMT_Cellular_Therapy Annalisa Ruggeri Florent Malard

Excellent presentation of Christian Chabannon on tisagenlecleucel for the Management of Patients with R/R DLBCL: an Interim Report of the European PASS Conducted by EBMT EBMT_Cellular_Therapy Annalisa Ruggeri




Getting ready for #EHA2025 ? IACH will be actively present in Milan with different exciting activities. Please visit our booth to learn more about our « Hematology Without Borders » mantra. European Hematology Association The EBMT Trainee Committee COMy

